Electromed (ELMD) Gains from Investment Securities (2024 - 2026)
Electromed's (ELMD) quarterly Gains from Investment Securities came in at -$94000.0 in Q1 2026, up 72.19% year-over-year from -$54591.1 in Q1 2025, and down 327.27% quarter-over-quarter from -$22000.0 in Q4 2025.
Powered by 
Analysis
Electromed (ELMD) Gains from Investment Securities (2024 - 2026) Analysis & Trends
Electromed (ELMD) has reported Gains from Investment Securities for 3 consecutive years, with -$94000.0 the latest figure, recorded in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Electromed | 222.94 Mn | 202.49 Mn | 15.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -94,000.00 |
| Dec 31, 2025 | -22,000.00 |
| Sep 30, 2025 | -81,000.00 |
| Mar 31, 2025 | -338,000.00 |
| Dec 31, 2024 | -135,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Mar 31, 2024 | -99,000.00 |